| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Found 14 studies with search of: | "4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol" |
|
Hide studies that are not seeking new volunteers.
|
|
| 1 | Completed | A Study of Gaboxadol in Primary Insomnia | ||||
| Condition: | Primary Insomnia | |||||
| Intervention: | Drug: Gaboxadol | |||||
| 2 | Completed | A Study of Gaboxadol in Primary Insomnia | ||||
| Condition: | Primary Insomnia | |||||
| Intervention: | Drug: Gaboxadol | |||||
| 3 | Completed | A Study of Gaboxadol in Primary Insomnia | ||||
| Condition: | Primary Insomnia | |||||
| Intervention: | Drug: Gaboxadol | |||||
| 4 | Completed | A Prospective Open-Label Extension Study of Gaboxadol in Primary Insomnia | ||||
| Condition: | Primary Insomnia | |||||
| Intervention: | Drug: Gaboxadol | |||||
| 5 | Completed | A Prospective Active-Reference Study of Gaboxadol in Primary Insomnia | ||||
| Condition: | Primary Insomnia | |||||
| Intervention: | Drug: Gaboxadol | |||||
| 6 | Completed | An Investigational Study of MK0928 in Adult Outpatients With Insomnia | ||||
| Condition: | Insomnia | |||||
| Interventions: | Drug: gaboxadol; Drug: Comparator: placebo (unspecified) | |||||
| 7 | Completed | Adult Primary Insomnia Polysomnographic Study | ||||
| Condition: | Primary Insomnia | |||||
| Interventions: | Drug: gaboxadol; Drug: Comparator: placebo (unspecified) | |||||
| 8 | Completed | Study of MK0928 in Healthy Adult Volunteers in a Model of Insomnia | ||||
| Condition: | Insomnia | |||||
| Intervention: | Drug: gaboxadol | |||||
| 9 | Completed | Safety of MK0928 on Insomnia in the Elderly | ||||
| Condition: | Insomnia | |||||
| Interventions: | Drug: MK0928, gaboxadol; Drug: Comparator: placebo | |||||
| 10 | Active, not recruiting | MK0928 Study in Adult Patients With Primary Insomnia | ||||
| Condition: | Primary Insomnia | |||||
| Interventions: | Drug: MK0928, gaboxadol / Duration of Treatment 3 Weeks; Drug: Placebo / Duration of Treatment 3 Weeks | |||||
| 11 | Terminated | An Investigational Drug Study in Healthy Adult Volunteers in a Model of Insomnia | ||||
| Condition: | Insomnia | |||||
| Intervention: | Drug: MK0928, gaboxadol / Duration of Treatment: 10 months | |||||
| 12 | Terminated | Elderly Primary Insomnia Polysomnographic Study | ||||
| Condition: | Primary Insomnia | |||||
| Interventions: | Drug: MK0928, gaboxadol / Duration of Treatment - 6 weeks; Drug: Comparator: placebo / Duration of Treatment - 6 weeks | |||||
| 13 | Completed | Efficacy and Safety of MK0928 for Insomnia in Adults | ||||
| Condition: | Insomnia | |||||
| Interventions: | Drug: MK0928, gaboxadol / Duration of Treatment - 1 year; Drug: Comparator: placebo / Duration of Treatment -1 year | |||||
| 14 | Terminated | Sleep Laboratory Study of MK0928 in Adult Patients With Primary Insomnia | ||||
| Condition: | Primary Insomnia | |||||
| Interventions: | Drug: MK0928, gaboxadol / Duration of Treatment: 6 days for treatment periods (2 days/dose); Drug: Placebo / Duration of Treatment: 2 days for screening period | |||||
|
